BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

714 related articles for article (PubMed ID: 29220688)

  • 1. Effects of surface modification and size on oral drug delivery of mesoporous silica formulation.
    Wang Y; Cui Y; Zhao Y; Zhao Q; He B; Zhang Q; Wang S
    J Colloid Interface Sci; 2018 Mar; 513():736-747. PubMed ID: 29220688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface functionalized mesoporous silica nanoparticles as an effective carrier for epirubicin delivery to cancer cells.
    Hanafi-Bojd MY; Jaafari MR; Ramezanian N; Xue M; Amin M; Shahtahmassebi N; Malaekeh-Nikouei B
    Eur J Pharm Biopharm; 2015 Jan; 89():248-58. PubMed ID: 25511563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virus-Mimicking Mesoporous Silica Nanoparticles with an Electrically Neutral and Hydrophilic Surface to Improve the Oral Absorption of Insulin by Breaking Through Dual Barriers of the Mucus Layer and the Intestinal Epithelium.
    Zhang Y; Xiong M; Ni X; Wang J; Rong H; Su Y; Yu S; Mohammad IS; Leung SSY; Hu H
    ACS Appl Mater Interfaces; 2021 Apr; 13(15):18077-18088. PubMed ID: 33830730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted modulation of cell differentiation in distinct regions of the gastrointestinal tract via oral administration of differently PEG-PEI functionalized mesoporous silica nanoparticles.
    Desai D; Prabhakar N; Mamaeva V; Karaman DŞ; Lähdeniemi IA; Sahlgren C; Rosenholm JM; Toivola DM
    Int J Nanomedicine; 2016; 11():299-313. PubMed ID: 26855569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overcoming multiple gastrointestinal barriers by bilayer modified hollow mesoporous silica nanocarriers.
    Wang Y; Zhao Y; Cui Y; Zhao Q; Zhang Q; Musetti S; Kinghorn KA; Wang S
    Acta Biomater; 2018 Jan; 65():405-416. PubMed ID: 29037897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comparative Study of the Use of Mesoporous Carbon and Mesoporous Silica as Drug Carriers for Oral Delivery of the Water-Insoluble Drug Carvedilol.
    Han C; Huang H; Dong Y; Sui X; Jian B; Zhu W
    Molecules; 2019 May; 24(9):. PubMed ID: 31067732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesoporous silica nanorods for improved oral drug absorption.
    Zheng N; Li J; Xu C; Xu L; Li S; Xu L
    Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1132-1140. PubMed ID: 28783976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrophilic and Electroneutral Nanoparticles to Overcome Mucus Trapping and Enhance Oral Delivery of Insulin.
    Tan X; Yin N; Liu Z; Sun R; Gou J; Yin T; Zhang Y; He H; Tang X
    Mol Pharm; 2020 Sep; 17(9):3177-3191. PubMed ID: 32697099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pH responsive cylindrical MSN for oral delivery of insulin-design, fabrication and evaluation.
    Guha A; Biswas N; Bhattacharjee K; Sahoo N; Kuotsu K
    Drug Deliv; 2016 Nov; 23(9):3552-3561. PubMed ID: 27540687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface engineering of silica nanoparticles for oral insulin delivery: characterization and cell toxicity studies.
    Andreani T; Kiill CP; de Souza AL; Fangueiro JF; Fernandes L; Doktorovová S; Santos DL; Garcia ML; Gremião MP; Souto EB; Silva AM
    Colloids Surf B Biointerfaces; 2014 Nov; 123():916-23. PubMed ID: 25466464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A surface-grafted ligand functionalization strategy for coordinate binding of doxorubicin at surface of PEGylated mesoporous silica nanoparticles: Toward pH-responsive drug delivery.
    Zhang Q; Zhao H; Li D; Liu L; Du S
    Colloids Surf B Biointerfaces; 2017 Jan; 149():138-145. PubMed ID: 27750088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-Delivery of Epirubicin and siRNA Using Functionalized Mesoporous Silica Nanoparticles Enhances In vitro and In vivo Drug Efficacy.
    Hanafi-Bojd MY; Jaafari MR; Ramezanian N; Abnous K; Malaekeh-Nikouei B
    Curr Drug Deliv; 2016; 13(7):1176-1182. PubMed ID: 26718488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesoporous Silica Molecular Sieve based Nanocarriers: Transpiring Drug Dissolution Research.
    Pattnaik S; Pathak K
    Curr Pharm Des; 2017; 23(3):467-480. PubMed ID: 27784249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of PEG-coated silica nanoparticles for oral insulin delivery.
    Andreani T; de Souza AL; Kiill CP; Lorenzón EN; Fangueiro JF; Calpena AC; Chaud MV; Garcia ML; Gremião MP; Silva AM; Souto EB
    Int J Pharm; 2014 Oct; 473(1-2):627-35. PubMed ID: 25089510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biotinylated-lipid bilayer coated mesoporous silica nanoparticles for improving the bioavailability and anti-leukaemia activity of Tanshinone IIA.
    Li Z; Zhang Y; Zhang K; Wu Z; Feng N
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):578-587. PubMed ID: 29374971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of mucoadhesive polymers on the in vitro performance of insulin-loaded silica nanoparticles: Interactions with mucin and biomembrane models.
    Andreani T; Miziara L; Lorenzón EN; de Souza AL; Kiill CP; Fangueiro JF; Garcia ML; Gremião PD; Silva AM; Souto EB
    Eur J Pharm Biopharm; 2015 Jun; 93():118-26. PubMed ID: 25843239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Food Protein Based Core-Shell Nanocarriers for Oral Drug Delivery: Effect of Shell Composition on in Vitro and in Vivo Functional Performance of Zein Nanocarriers.
    Alqahtani MS; Islam MS; Podaralla S; Kaushik RS; Reineke J; Woyengo T; Perumal O
    Mol Pharm; 2017 Mar; 14(3):757-769. PubMed ID: 28103046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of mesoporous silica nanoparticles for oral drug delivery - current status and perspective of MSNs drug carriers.
    Florek J; Caillard R; Kleitz F
    Nanoscale; 2017 Oct; 9(40):15252-15277. PubMed ID: 28984885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility Study of the Permeability and Uptake of Mesoporous Silica Nanoparticles across the Blood-Brain Barrier.
    Baghirov H; Karaman D; Viitala T; Duchanoy A; Lou YR; Mamaeva V; Pryazhnikov E; Khiroug L; de Lange Davies C; Sahlgren C; Rosenholm JM
    PLoS One; 2016; 11(8):e0160705. PubMed ID: 27547955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applications of mesoporous materials as excipients for innovative drug delivery and formulation.
    Shen SC; Ng WK; Chia LS; Dong YC; Tan RB
    Curr Pharm Des; 2013; 19(35):6270-89. PubMed ID: 23470004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.